|
California Medical License |
Centinela Hospital Medical Center
Torrance Memorial Medical Center
Daniel Freeman Memorial Medical Center
Robert F. Kennedy Medical Center
Little Company of Mary Medical Center
South Bay Hospital
UC Irvine Medical Center
Phase
II Trial in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer.
Double-Blind,
Placebo-Controlled, prevention of Acute & Delayed Chemotherapy-Induced
Emesis.
Double-Blind,
Placebo-Controlled, of acute and delayed Chemotherapy-Induced Emesis.
A Randomized, double-blind, placebo controlled, multicenter evaluation for the efficacy and safety of SMS 201-995 pa LAR given with 5-FU in the treatment of patients with Stage IV Pancreatic Cancer.
Phase III randomized trial of 5-U/Leucovorin/Levamisole versus 5-FU continuous infusion/Levamisole as adjuvant therapy for high risk respectable colon cancer, intergroup.
A Phase II trial of Taxol, with Carboplatin in patients with advanced head and neck cancer.
Phase II study of chemotherapy with Bactrim, AZT, G-CSF inpatients with AIDS related lymphoma.
Phase III Intergroup trial of adjuvant chemoradiation after gastric resection for adenocarcinoma.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Safety, Tolerability, and Efficacy of MK-0869 for the Prevention of Chemo-Induced Nausea and Vomiting Associated with High-Dose Cisplatin.
Phase III Trial in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Who Were Previously Treated with Chemotherapy.
Phase III Study in Patients with Unresectable, Locally Recurrent or Metastatic Breast Cancer.
| ABOUT CHOMG | CHOMG EVENTS | TO CHOMG |
| RESOURCE PAGE | TO BIOS | HOME |
| BACK TO CHOMG STAFF | EMAIL US |